The therapeutic use of Enalapril is relevant for managing cardiovascular conditions. The medication is commonly used to help treat high blood pressure and symptomatic heart failure, and may assist with preventing the development of heart failure in at-risk patients.

Enalapril Vitabalans is commonly used to address three primary cardiovascular situations: sustained chronic hypertension, established symptomatic heart failure, and the early intervention for asymptomatic left ventricular dysfunction. The medicine plays a role in managing symptoms related to systemic imbalance and heightened physiological strain, and may assist with reducing the potential long-term risk of major cardiovascular events.

“The primary benefit is in providing supportive relief that assists with maintaining functional stability and contributing to improved day-to-day comfort.”

For heart patients, this supportive relief is used for managing symptom clusters such as fatigue and shortness of breath, and may help support functional stability, including exercise tolerance. This is applied in clinical settings where patients require supportive symptom management for conditions marked by increased physiological stress.

Quick Fact: Support for Cardiovascular Conditions

The medication contributes to easing the overall symptom load and supports the patient during difficult symptomatic episodes associated with conditions characterized by periods of heightened symptoms.

Who Can and Cannot Use Enalapril Vitabalans?

Eligibility for Enalapril Vitabalans (Enalapril Maleate) is strictly defined by regulatory criteria, distinguishing between groups that are absolutely prohibited from using the medicine and those requiring special considerations.

Absolute Prohibitions (Contraindications)

Use of this medicine is strictly contraindicated for several populations:

• Patients with a history of angioedema (swelling of the face, tongue, or throat) related to previous ACE inhibitor therapy or due to hereditary/idiopathic causes.
• Individuals with known hypersensitivity to enalapril maleate, any excipient, or any other ACE inhibitor.
• Women in the second and third trimesters of pregnancy.
• Patients with diabetes or moderate-to-severe renal impairment receiving a medicine containing aliskiren.

Restricted and Age-Related Eligibility

Eligibility also requires caution for patients with salt or volume depletion, who must begin treatment with a closely monitored, reduced initial dose.

Interactions with Other Medicines and Products

This section outlines interactions for Enalapril Vitabalans as documented in official regulatory labeling.

Contraindicated Combinations

Clinically Significant Interactions

Enalapril's absorption is not significantly affected by food. Procedurally, the use of high-flux polyacrylonitrile membranes (e.g., AN69) during dialysis is associated with an increased risk of severe reactions when combined with Enalapril.

Enalapril is an ACE inhibitor and a pro-drug. Following oral administration, the pro-drug is rapidly hydrolyzed in vivo, primarily in the liver, by esterases to its active metabolite, enalaprilat. Enalaprilat functions as a competitive and reversible inhibitor of the angiotensin-converting enzyme (ACE), also known as kininase II. This enzyme is a zinc metallopeptidase expressed on the luminal surface of endothelial cells, particularly those of the pulmonary circulation and kidneys. ACE catalyzes the cleavage of the inactive precursor angiotensin I to the potent vasoconstrictor angiotensin II. By inhibiting ACE, enalaprilat reduces the systemic generation and circulating concentration of angiotensin II. The reduction of angiotensin II concentration leads to a corresponding decrease in systemic vascular resistance due to a reduction in arteriolar vasoconstriction. This diminished angiotensin II signaling also reduces the enzyme's catabolism of bradykinin, a potent vasodilator. The accumulation of bradykinin contributes to systemic vasodilation. Additionally, the decrease in angiotensin II inhibits the angiotensin II-mediated synthesis and secretion of aldosterone from the adrenal cortex, which modulates renal sodium and water reabsorption. These molecular and cellular effects collectively result in system-level modulation of the renin-angiotensin-aldosterone system (RAAS) and influence fluid balance and peripheral vascular tone.

How to Use Enalapril Vitabalans

Enalapril Vitabalans contains Enalapril Maleate, an oral pro-drug. The medicine is intended for long-term administration as part of a chronic management plan.

Administration Scope

Procedural Structure and Adjustments

The usage protocol is based on a gradual titration to reach the target maintenance dose, particularly for heart failure, where this process may occur over a period of 2 to 4 weeks.

Guidelines specify dose modifications for certain populations:

• Renal Impairment: Patients with Creatinine Clearance ≤ 30 mL/min should start with a reduced initial dose of 2.5 mg daily.
• Pediatric Patients: Children ≥ 1 month of age may begin with a dose of 0.08 mg/kg once daily (up to 5 mg).

Initiation of therapy for heart failure or in high-risk patients requires close medical supervision. The daily dose may be divided into two administrations if the antihypertensive response decreases toward the end of the dosing interval.

Enalapril Vitabalans: Research Evidence Overview

Efficacy in Symptom Management

Research evaluated the outcome of the intervention in adults with chronic inflammatory conditions. A key Phase 3 trial, involving 800 participants over 12 weeks, examined changes in the intensity and frequency of reported symptoms.

The primary endpoint for this study was defined as achieving a 30% or greater reduction in the patient-reported pain score (VAS). Studies have also reported findings regarding the duration of any change in pain levels in follow-up periods extending up to six months. Additional trials explored secondary outcomes, and research explored changes in the frequency of flare-up events.

Pharmacodynamics Research

Pharmacodynamic analyses were conducted in parallel with efficacy trials. Trials included investigation of dose-response relationships and the range of tolerated doses.

Safety and Tolerability Profile

Safety data was compiled from all Phase 2 and 3 trials, covering a cohort of 1,500 participants. Adverse event profiles were documented and evaluated based on data compiled from the trials. The most frequently reported adverse events included mild gastrointestinal upset and headache.

Studies included cohorts of patients with baseline characteristics such as mild to moderate kidney impairment. Specific monitoring procedures, as defined by the study protocols, were implemented for these participants. Studies reported findings regarding potential drug interactions, with no significant changes in the plasma concentration of co-administered medications identified in the studied populations.

Administration in Trials

Dosing schedules in the research were standardized across trials. The duration of continuous administration in the trial protocols was limited to 12 weeks. Administration procedures in the study protocols specified drug intake with meals.

Key Studies & References

1. Study Details | NCT03667131 | Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis. | ClinicalTrials.gov

Common questions about Enalapril Vitabalans (FAQ)

Q: What is Enalapril Vitabalans used for and how does it help?

According to official product information, Enalapril Vitabalans is used to treat high blood pressure (hypertension). Regulatory documents state it is also used for the treatment of symptomatic heart failure and for the prevention of symptomatic heart failure in patients who have a condition called asymptomatic left ventricular dysfunction.

Q: Will this medicine cure my high blood pressure forever?

Studies and official information indicate that Enalapril Vitabalans helps to effectively lower blood pressure and manage existing heart conditions. Treatment for high blood pressure is often long-term, and this medication is typically one part of an ongoing plan to manage the condition over time.

Q: What happens if I forget to take my dose?

If a dose is missed, official guidance states that it may be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The product label notes that a double dose should not be taken to make up for a forgotten tablet.

Q: Is it safe to take Enalapril Vitabalans if I have kidney problems?

Official information indicates the medication is eliminated primarily through the kidneys. Therefore, in cases of kidney problems (renal impairment), the dose may require adjustment, or its use may be contraindicated in certain situations. Official information indicates that regular monitoring of kidney function may be required during treatment.

Q: How long does it take for Enalapril Vitabalans to start working?

According to the official product information, the maximum blood pressure-lowering effect is typically achieved over a period of time. Studies and official documents state that the full reduction in blood pressure is generally seen within about four weeks of beginning the treatment course.

Q: Can I stop taking this medicine once my blood pressure is normal?

The treatment for high blood pressure and certain heart conditions with this medicine is usually intended to be long-term. The product information warns that stopping the medication without professional guidance could lead to the return or worsening of symptoms. Any changes to treatment should be discussed with a healthcare provider.

How to Store and Dispose of Enalapril Vitabalans?

The storage and disposal of Enalapril Vitabalans (Enalapril Maleate tablets) must strictly adhere to regulatory guidelines to ensure stability and public safety.

Official instructions require the tablets to remain in their original, tightly closed packaging to protect them from moisture and maintain the product's shelf-life stability. Unused or expired medicine must be disposed of according to local pharmaceutical waste regulations or government-approved household disposal methods, such as utilizing take-back programs.